v3.25.2
Consolidated Sponsored Investment Products
6 Months Ended
Jun. 30, 2025
Statement of Financial Position [Abstract]  
Consolidated Sponsored Investment Products

6. Consolidated Sponsored Investment Products

In the normal course of business, the Company is the manager of various types of sponsored investment products, which may be considered VIEs or voting rights entities ("VREs"). The Company consolidates certain sponsored investment funds accounted for as VREs because it is deemed to control such funds. In addition, the Company may from time to time own equity or debt securities issued by vehicles or enter into derivatives or loan arrangements with the vehicles, each of which are considered variable interests. The Company’s involvement in financing the operations of the VIEs is generally limited to its economic interest in the entity. The Company’s consolidated VIEs include certain sponsored investment products in which BlackRock has an economic interest and as the investment manager, is deemed to have both the power to direct the most significant activities of the products and the right to receive benefits (or the obligation to absorb losses) that could potentially be significant to these sponsored investment products. The assets of these VIEs are not available to creditors of the Company. In addition, the investors in these VIEs have no recourse to the credit of the Company.

The following table presents the balances related to these CIPs accounted for as VIEs and VREs that were recorded on the condensed consolidated statements of financial condition, including BlackRock’s net interest in these products:

 

 

June 30, 2025

 

 

December 31, 2024

 

(in millions)

 

VIEs

 

 

VREs

 

 

Total

 

 

VIEs

 

 

VREs

 

 

Total

 

Cash and cash equivalents(1)

 

$

196

 

 

$

39

 

 

$

235

 

 

$

125

 

 

$

44

 

 

$

169

 

Investments:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Trading debt securities

 

 

1,687

 

 

 

408

 

 

 

2,095

 

 

 

1,497

 

 

 

246

 

 

 

1,743

 

Equity securities at FVTNI

 

 

1,366

 

 

 

391

 

 

 

1,757

 

 

 

1,179

 

 

 

377

 

 

 

1,556

 

Loans

 

 

104

 

 

 

3

 

 

 

107

 

 

 

141

 

 

 

4

 

 

 

145

 

Other investments

 

 

843

 

 

 

39

 

 

 

882

 

 

 

370

 

 

 

33

 

 

 

403

 

Carried interest

 

 

2,045

 

 

 

 

 

 

2,045

 

 

 

1,905

 

 

 

 

 

 

1,905

 

Total investments

 

 

6,045

 

 

 

841

 

 

 

6,886

 

 

 

5,092

 

 

 

660

 

 

 

5,752

 

Other assets

 

 

128

 

 

 

118

 

 

 

246

 

 

 

45

 

 

 

31

 

 

 

76

 

Other liabilities(2)

 

 

(2,340

)

 

 

(118

)

 

 

(2,458

)

 

 

(2,130

)

 

 

(93

)

 

 

(2,223

)

Noncontrolling interest - CIPs

 

 

(2,213

)

 

 

(193

)

 

 

(2,406

)

 

 

(1,672

)

 

 

(130

)

 

 

(1,802

)

BlackRock's net interest in CIPs

 

$

1,816

 

 

$

687

 

 

$

2,503

 

 

$

1,460

 

 

$

512

 

 

$

1,972

 

 

(1)
The Company generally cannot readily access cash and cash equivalents held by CIPs to use in its operating activities.
(2)
At both June 30, 2025 and December 31, 2024, other liabilities of VIEs primarily include deferred carried interest liabilities and borrowings of a consolidated CLO.

BlackRock’s total exposure to CIPs represents the value of its economic interest in these CIPs. Valuation changes associated with financial instruments held at fair value by these CIPs are reflected in nonoperating income (expense) and partially offset in net income (loss) attributable to NCI for the portion not attributable to BlackRock.

Net gain (loss) related to consolidated VIEs is presented in the following table:

 

 

Three Months Ended

 

 

Six Months Ended

 

 

 

June 30,

 

 

June 30,

 

(in millions)

 

2025

 

 

2024

 

 

2025

 

 

2024

 

Nonoperating net gain (loss) on consolidated VIEs

 

$

144

 

 

$

66

 

 

$

156

 

 

$

137

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income (loss) attributable to NCI on consolidated VIEs

 

$

71

 

 

$

46

 

 

$

79

 

 

$

85